Yoshimura Food Holdings K.K. Logo

Yoshimura Food Holdings K.K.

Acquires and revitalizes Japanese food SMEs via a support platform for global expansion.

2884 | T

Overview

Corporate Details

ISIN(s):
JP3958400008
LEI:
Country:
Japan
Address:
千代田区内幸町二丁目2番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Yoshimura Food Holdings K.K. is a holding company dedicated to preserving and growing Japan's food culture. Its core business is the merger and acquisition (M&A) of food-related small and medium-sized enterprises (SMEs) that possess high-quality products and unique manufacturing techniques but face business succession or growth challenges. The company operates a unique "SME support platform," providing comprehensive management assistance to its group companies in areas such as sales, marketing, and product development. This model focuses on long-term value creation and synergy, aiming to revitalize acquired businesses and expand the reach of their diverse food products to both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-15 09:06
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-10-15 09:05
Interim Report
半期報告書-第18期(2025/03/01-2026/02/28)
Japanese 207.9 KB
2025-06-02 07:08
Post-Annual General Meeting Information
臨時報告書
Japanese 21.4 KB
2025-05-30 07:25
Registration Form
確認書
Japanese 8.1 KB
2025-05-30 07:24
Governance Information
内部統制報告書-第17期(2024/03/01-2025/02/28)
Japanese 22.1 KB
2025-05-30 07:23
Annual Report
有価証券報告書-第17期(2024/03/01-2025/02/28)
Japanese 1.2 MB
2025-04-15 08:08
Management Discussion and Analysis
臨時報告書
Japanese 18.9 KB
2025-04-08 09:53
Capital/Financing Update
臨時報告書
Japanese 19.5 KB
2025-02-28 08:07
Capital/Financing Update
臨時報告書
Japanese 19.3 KB
2025-01-10 06:53
Regulatory News Service
臨時報告書
Japanese 18.5 KB
2024-12-09 08:34
Legal Proceedings Report
臨時報告書
Japanese 18.6 KB
2024-10-15 09:46
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-10-15 09:45
Interim Report
半期報告書-第17期(2024/03/01-2025/02/28)
Japanese 199.7 KB
2024-07-12 08:42
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-07-12 08:41
Quarterly Report
四半期報告書-第17期第1四半期(2024/03/01-2024/05/31)
Japanese 158.7 KB

Automate Your Workflow. Get a real-time feed of all Yoshimura Food Holdings K.K. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Yoshimura Food Holdings K.K.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Yoshimura Food Holdings K.K. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.